FSCA and Recall Obligations for Medical Devices in Kenya

Content verification date: October 30, 2026

1. Key takeaways

• The harshest design Kenya applies to FSCA lies not in penalties but in procedural linkage: Section 2.7 of the Guidelines for Registration of Medical Devices including In-Vitro Diagnostics (HPT/PER/HTR/GUD/011) provides that where a device is currently subject to a Field Safety Corrective Action (FSCA), its registration application will be stop-clocked until the FSCA is resolved.
• FSCA is the seventh of the ten LAR duties, expressed as the implementation, management, coordination and reporting of FSCAs. This means an overseas manufacturer cannot execute a recall in Kenya on its own; it must land the action through the LAR.
• Article 7 of the Guidelines on Submission of Documentation for Registration of Medical Devices lists establishing an FSCA procedure as one of the six post-market obligations of manufacturers and the LAR. The procedure must exist before the event, not be patched together after it.
• A gate is already built into establishment registration: when applying for a certificate under the Guidelines for Registration of Medical Devices Establishments (PRA/LPP/GUD/072), the official contact person must declare that procedures for complaint handling, FSCA, and the handling and disposal of substandard and falsified products are documented.
• There is also a knock-on effect at pathway level: both EBR and IBR require that at submission there is no open FSCA (including recalls) and no global safety issues for the past 3 years. A single open FSCA closes Kenya’s accelerated routes at the same time.

2. Legal basis

3. Expert insights

Insight 1: the Section 2.7 FSCA stop-clock is Kenya’s most underestimated provision

GRZAN considers this provision more consequential than any fine. It connects a post-market event directly to a pre-market procedure: once a device enters FSCA status in Kenya or another market, its pending Kenyan application is stop-clocked, and stop-clock time is excluded from the review timeline. More importantly, the text does not confine the FSCA to Kenya; the wording is simply that the device is under an FSCA. On a strict reading, a recall initiated in an overseas market can equally trigger the stop-clock. For companies, global recalls and pending Kenyan projects must therefore be managed in a linked way, otherwise Kenyan projects stall without anyone owning the explanation.

Insight 2: the stop-clock cuts both ways, so proactive disclosure beats being discovered

Section 2.7 also contains a general stop-clock rule: it runs from the issuance of PPB’s additional information request until a complete and satisfactory response is received. The FSCA stop-clock sits alongside it, which shows that PPB treats an FSCA as an open item on the applicant side. GRZAN’s judgement is that since the stop-clock is unavoidable, the value of proactive disclosure lies in shortening its duration. Having the LAR submit the FSCA notification, scope statement, corrective action plan and expected closure timeline to PPB as soon as a recall starts is far more favourable than being found through another regulator’s public notices or market surveillance. The latter not only stops the clock but may also breach the reporting duty under Rule 13(2), opening the withholding, suspension or revocation route under Rule 11.

Insight 3: the seventh LAR duty locks recall execution locally

Among the ten LAR duties, the seventh covers the implementation, management, coordination and reporting of FSCAs, the fourth covers adverse event and incident reporting, and the sixth covers product safety vigilance reports. Splitting these into separate duties shows that Kenya treats reporting and execution as two distinct actions. The common mistake of overseas manufacturers is to regard sending a recall notice to distributors as mission accomplished. Under the Kenya framework, implementation, management and coordination of an FSCA are statutory LAR duties: the manufacturer must co-sign a recall execution plan with the LAR defining the recovery scope, customer notification method, replacement or repair arrangements, disposal destination and effectiveness assessment, with the LAR reporting to PPB in a unified manner.

Insight 4: an open FSCA closes accelerated and immediate routes in reverse

Kenya’s accelerated routes impose hard requirements on safety history. EBR requires approval by at least 2 Reference Regulatory Agencies (RRA), marketing in the relevant jurisdiction for at least 3 years, and no global safety issues for the past 3 years, expressly including no open field safety corrective actions (including recalls) at submission, no death reports and no reports of serious deterioration in health. IBR likewise requires no safety issues for the past 3 years. GRZAN therefore notes that a single FSCA affects not only the current project but whether that product line can use EBR and IBR at all for the next 3 years. When assessing whether a recall is necessary, the loss of pathway eligibility should be part of the decision model.

4. Practical recommendations

1. Add a dedicated FSCA execution clause to the LAR agreement. GRZAN recommends defining the notification duty on recall initiation, the scope of LAR support, cost bearing and external messaging, so that disputes over whether to act do not arise mid-crisis.
2. Build a global event linkage mechanism. Whenever a recall is initiated in any market, immediately search pending Kenyan applications and marketed products, and notify the LAR within 24 hours.
3. Pre-build recall templates. Prepare the FSCA notification letter, customer notification letter, recovery record form and effectiveness assessment form in advance, in English versions included, to shorten the stop-clock period.
4. Where pending applications are affected, explain proactively in writing. Have the LAR submit a situation statement and expected closure timeline to PPB, and seek written confirmation to fix the clock-resumption point.
5. Review pathway eligibility once a year. Check annually whether each product line still meets the 3-year no-safety-issue requirement for EBR and IBR, and feed FSCA records into pathway planning.
6. Route disposal through the exemption channel first. For export or destruction of recalled devices, submit the notification and supporting documents to PPB under Section 2.14 in advance.

5. Verification checklist

• □ Is the FSCA procedure documented, covering notification, execution, coordination and reporting?
• □ Has the LAR confirmed in writing that it assumes the seventh duty, with the staff and channels to execute a recall?
• □ Can a global recall event be linked to the list of pending Kenyan applications within 24 hours?
• □ Are English versions of the FSCA notification letter, customer notification letter and recovery record form pre-built?
• □ Is any pending application currently stop-clocked because of an FSCA, and is the stop-clock start date recorded?
• □ Does each product line meet the no-safety-issues-for-3-years and no-open-FSCA requirements for EBR and IBR?
• □ Has the exemption notification for export or destruction of recalled devices been submitted in advance?

Regulatory information verified as of October 30, 2026.

In African markets, the GRZAN regulatory team focuses on Kenya, Nigeria, South Africa and Egypt and verifies every published regulatory conclusion against official gazettes, competent authority guidelines and public legal databases, with the verification date marked; figures, cycles and amounts not locatable in official sources are marked as practical estimates, not presumed.

GRZAN services cover market access strategy and risk classification; preparation and review of dossiers in CSDT, STED and CTD formats; selection and management of Local Authorized Representatives (LAR); QMS and GMP/GSDP compliance support; post-market vigilance, change management and recall response; import clearance and PVoC coordination; regulatory intelligence subscriptions and compliance ledgers.

For a Kenya post-market compliance programme covering FSCA execution, recall response and inspection readiness for your specific products, please contact the GRZAN regulatory team at info@grzanglobal.com.